Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients

Conclusion. In this pediatric population, CDI risk in children receiving home acid-suppressive therapy with H2RAs is nearly 4.5 times greater than that of children not receiving H2RA therapy. These results suggest the need for continued monitoring and study of H2RA therapy in children.

Source: Clinical Pediatrics - September 9, 2015 Category: Pediatrics Authors: Brown, K. E., Knoderer, C. A., Nichols, K. R., Crumby, A. S. Tags: Articles Source Type: research